PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:15 AM ET

Sponsor Check › Person

EP
No photo found yet (own website and image search run after this page is viewed)

Ed Penhoet

Named as an officer, director or promoter on SEC Form D filings · CA, WA · Jul 8, 2009 → Apr 2, 2015

3deals (issuers)
$136.2Mreported sold
61investors
11Form D filings
2009–2015years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:02 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Ed Penhoet is listed as a director on 11 SEC Form D filings by 3 issuers between Jul 2009 and Apr 2015: aTYR PHARMA INC (San Diego, CA — biotechnology — 2015; $76.3M reported sold to 42 investors), Immune Design Corp. (Seattle, WA — biotechnology — 2009–2014; $48.5M reported sold to 8 investors) and SCYNEXIS INC (Durham, NC — pharmaceuticals — 2011–2012; $11.4M reported sold to 11 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $136.2M sold in total.

Listed alongside Brian Atwood (7 shared filings), David Baltimore (7 shared filings), Carlos V. Paya (4 shared filings), Jan Henrik ter Meulen (4 shared filings), Peter Svennilson (4 shared filings) and 31 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ed. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 11 public filings for Ed Penhoet and found 11 differences, 5 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Ed Penhoet has not run yet — it is joining a line of 10,980 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ed Penhoet..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Ed Penhoet — 5 worth asking about (compared 11 filings on Oct 24, 2026)

Worth asking · Jul 29, 2009 – Oct 6, 2009

Amount sold went down between filings — Immune Design Corp.

The Jul 29, 2009 filing says $14,000 sold; the Oct 6, 2009 Form D says $10,500 sold — $3,500 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Sources
Worth asking · Jul 8, 2009 – Jul 29, 2009

Amount sold went down between filings — Immune Design Corp.

The Jul 8, 2009 filing says $14,000,000 sold; the Jul 29, 2009 Form D says $14,000 sold — $13,986,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Sources
Worth asking · Jul 8, 2009 – Jul 29, 2009

Investor count went down between filings — Immune Design Corp.

The Jul 8, 2009 filing reports 4 investors; the Jul 29, 2009 Form D reports 1 investor.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Sources
Worth asking · Mar 10, 2011 – Jun 12, 2014

Form D filed 1,190 days after the first sale — Immune Design Corp.

The filing says the first sale was Mar 10, 2011. The Form D was filed Jun 12, 2014 — 1,190 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1,175 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Sources
Worth asking · Feb 20, 2008 – Jun 11, 2014

Form D filed 2,303 days after the first sale — Immune Design Corp.

The filing says the first sale was Feb 20, 2008. The Form D was filed Jun 11, 2014 — 2,303 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2,288 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Sources
Note · Jul 29, 2009 – Oct 6, 2009

Offering amount lowered between filings — Immune Design Corp.

The Jul 29, 2009 filing says $14,000 offered; the Oct 6, 2009 Form D says $10,500.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Jul 8, 2009 – Jul 29, 2009

Offering amount lowered between filings — Immune Design Corp.

The Jul 8, 2009 filing says $18,000,000 offered; the Jul 29, 2009 Form D says $14,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Oct 16, 2013 – Oct 31, 2013

No amendment in the last 12 months on an offering that may still be open — Immune Design Corp. (latest filing Oct 31, 2013)

The latest filing for this offering is dated Oct 31, 2013 (first sale Oct 16, 2013). It reports $48,450,000 sold of $57,750,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Dec 7, 2011 – May 18, 2012

No amendment in the last 12 months on an offering that may still be open — SCYNEXIS INC (latest filing May 18, 2012)

The latest filing for this offering is dated May 18, 2012 (first sale Dec 7, 2011). It reports $11,449,343 sold of $15,007,500 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Oct 6, 2009 – Oct 31, 2013

Address moved from San Francisco, CA to Seattle, WA — Immune Design Corp.

The people listed on the Oct 6, 2009 filing give San Francisco, CA; on the Oct 31, 2013 filing they give Seattle, WA. The address now on file (1616 Eastlake Ave. E, Suite 310, Seattle, WA) is a registered-agent or shared-office address used by 12 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Sources
Note · Jul 8, 2009 – Apr 2, 2015

Ed Penhoet is listed with 2 different address states: CA, WA

CA on 7 filings (Jul 8, 2009 to Apr 2, 2015); WA on 4 filings (Oct 31, 2013 to Jun 12, 2014).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 6 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 2, 2015 D
aTYR PHARMA INC
File 021-237156
$0$0$0None listed on this filingEDGAR ↗
Jun 12, 2014 D
Immune Design Corp.
File 021-219014
$0$0$0None listed on this filingEDGAR ↗
Jun 11, 2014 D/A
Immune Design Corp.
File 021-119253
$0$0$0None listed on this filingEDGAR ↗
Jun 11, 2014 D
Immune Design Corp.
File 021-218940
$0$0$0None listed on this filingEDGAR ↗
Oct 31, 2013 D
Immune Design Corp.
File 021-205531
$0$0$0None listed on this filingEDGAR ↗
May 18, 2012 D/A
SCYNEXIS INC
File 021-170229
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Ed Penhoet on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

aTYR PHARMA INC

San Diego, CA · Apr 2, 2015
  • Apr 2, 2015 · D · $76,278,755 sold of $76,278,755 · 42 investors · min. No minimum reported · role: Director (Non-Management Director) EDGAR ↗

Raised $76.3M from 42 investors (100% of the $76.3M target) as of the latest filing. Ed is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Immune Design Corp.

Seattle, WA · Jul 8, 2009 → Jun 12, 2014 · 7 filings
  • Jun 12, 2014 · D · $17,500 sold of $17,500 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 11, 2014 · D · $10 sold of $10 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 11, 2014 · D/A · $10,500 sold of $10,500 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 31, 2013 · D · $48,450,000 sold of $57,750,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 6, 2009 · D · $10,500 sold of $10,500 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 29, 2009 · D · $14,000 sold of $14,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 8, 2009 · D/A · $14,000,000 sold of $18,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $48.5M from 8 investors (100% of the $18K target) as of the latest filing. Ed is listed as director on 7 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

SCYNEXIS INC

Durham, NC · Dec 16, 2011 → May 18, 2012 · 3 filings
  • May 18, 2012 · D/A · $11,449,343 sold of $15,007,500 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 3, 2012 · D/A · $5,724,671 sold of $15,007,500 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 16, 2011 · D · $5,502,750 sold of $15,007,500 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.4M from 11 investors (76% of the $15M target) as of the latest filing. Ed is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Ed 36

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

BA
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Atwood

Director · 7 shared filings (1 issuer) · also on 14 other issuers

Brian Atwood is on 15 issuers in total — a repeat sponsor. Their page lists every one.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Baltimore

Director · 7 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Carlos V. Paya

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

WG
No photo found yet (own website and image search run after this page is viewed)
Person

Wayne Gombotz

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jan Henrik ter Meulen

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Svennilson

Director · 4 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard T. Kenney

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen R. Brady

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Ann F. Hanham

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Reed

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Klausner

Director · 3 shared filings (1 issuer) · also on 7 other issuers

Richard Klausner is on 8 issuers in total — a repeat sponsor. Their page lists every one.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Mounia Chaoui

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Langlois

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jean-Yves Nothias

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

PK
No photo found yet (own website and image search run after this page is viewed)
Person

Pamela J. Kirby

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

CO
No photo found yet (own website and image search run after this page is viewed)
Person

Charles F. Osborne, Jr.

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Schwab

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

LA
No photo found yet (own website and image search run after this page is viewed)
Person

Laurent Arthaud

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

YR
No photo found yet (own website and image search run after this page is viewed)
Person

Yves J. Ribeill

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

PR
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Rickey

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

William Ringo

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

FB
No photo found yet (own website and image search run after this page is viewed)
Person

Franklin Berger

Director · 3 shared filings (1 issuer) · also on 12 other issuers

Franklin Berger is on 13 issuers in total — a repeat sponsor. Their page lists every one.

HN
No photo found yet (own website and image search run after this page is viewed)
Person

Horace D. Nalle

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Amir Nashat

Director · 1 shared filing (1 issuer) · also on 28 other issuers

Amir Nashat is on 29 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

John Mendlein

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Carter

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Bruce Carter is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Weiner

Executive Officer · 1 shared filing (1 issuer) · also on 4 other issuers

David Weiner is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Blair

Director · 1 shared filing (1 issuer) · also on 18 other issuers

James Blair is on 19 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alain Schreiber

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

James Paul Rickey

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jose Barella

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Schimmel

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Akkaraju Srinivas

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John K. Clarke

Director · 1 shared filing (1 issuer) · also on 6 other issuers

John K. Clarke is on 7 issuers in total — a repeat sponsor. Their page lists every one.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Kathryn Falberg

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Frederic Chereau

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Ed Penhoet. Their page shows their other deals.

The team behind the deals

Same business address

12 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Ed Penhoet by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Ed Penhoet is listed on: none on file. No website or social profile named in aTYR PHARMA INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #266,954 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Ed Penhoet appears on a new Form D, or when a court case or SEC action is matched to them. See plans →